Type
Business expansion
Country
Greece
Region
Attiki; Attiki; Anatoliki Attiki
Location of affected unit(s)
Keratea, Attiki
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 - Manufacture of pharmaceutical preparations

300 jobs
Number of planned job creations
Job creation
Announcement Date
10 June 2026
Employment effect (start)
10 June 2026
Foreseen end date
31 December 2026

Description

ELPEN, a Greek pharmaceutical company operating in pharmaceutical manufacturing, is creating 300 jobs at its new production facility in Keratea, East Attica. According to ELPEN’s current facilities information, New Plant I in Keratea covers 15,000 square metres, employs 300 people and manufactures inhalation products, tablets and capsules, with annual full-capacity output of 71 million packages.

ELPEN’s wider investment programme also foresees additional job creation through the expansion of its Pikermi facilities, a second Keratea plant planned for 2026–2027, a distribution centre in Markopoulo and a new oncology drugs plant in Tripoli with Win Medica.


Citation

Eurofound (2026), ELPEN, Business expansion in Greece, factsheet number 300623, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/300623.